Navigation Links
New Treatment Option For Testicular Cancer

New research shows a significant improvement in treatment for a specific type of testicular cancer called stage I seminoma. Stage I seminoma is typically treated by // removal of the testicle followed by radiation. Radiation, though, poses a risk of developing a second cancer in another organ up to 20 years later.

Researchers randomized more than 540 patients to receive a single course of the drug carboplatin and more than 900 patients to receive radiation, which is the standard of care. The carboplatin group received one dose in one day, a protocol designed to treat ovarian cancer. The drug works by interfering with the growth of cancer cells, which eventually are destroyed.

After about three years, researchers found no difference in tumor control between the two groups, but that the single dose of carboplatin led to a reduced occurrence of a second tumor. At follow-up, there was only one second tumor noted in the carboplatin group and seven cases of second tumors noted in the radiation therapy group.

Thus researchers say that their trial shows that one shot of carboplatin in the short term is as safe as radiation, is less toxic, and might open the ways to using chemotherapy for testis conservation.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Treatment Option For Testicular Cancer

(Date:8/30/2014)... California (PRWEB) August 30, 2014 ... the release of the TransGhost plugin from Pixel Film ... that gives users the ability to tell their scary ... of Pixel Film Studios. “Users will make their audience ... transition plugin.” , With TransGhost users can awaken evil ...
(Date:8/30/2014)... August 30, 2014 The SI Joint ... mobilizations and six muscle energy techniques. Michael P. Reiman ... demonstrates twenty-seven examination techniques for the SI Joint. ... Dr. Reiman's live course presentation with North American Seminars. ... Applying a differential diagnosis approach to a ...
(Date:8/30/2014)... Atlanta, GA (PRWEB) August 30, 2014 ... US Open Challenge and K.Warrior Search on November 8th, ... Over 20 years, these events have introduced many notorious ... such as Strike-Force, IWF and the UFC. , ... seen numerous fighters leave its doors armed with the ...
(Date:8/30/2014)... Saturday 30 August 2014: The first multidisciplinary ... with acute coronary syndromes (ACS) are published today ... paper was written jointly by the European Heart ... (ACCA) and the European Association of Percutaneous Cardiovascular ... Professor Bulent Gorenek (Turkey), chairperson of the task ...
(Date:8/30/2014)... August 2014: The first recommendations on the use ... are published today in new ESC Guidelines. The ... Stavros V. Konstantinides (Germany/Greece) and Professor Adam Torbicki ... diagnosis and management of acute pulmonary embolism" are ... and on the ESC Website. , Venous thromboembolism ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 3Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2
... 4 (HealthDay News) -- Rates of head and neck cancer ... without any known risk factors. Now, a study suggests that ... of precancerous cells in the mouth. Previous research ... the lungs are exposed to smoke. This may lead to ...
... study of its kind, a research team led by Michigan ... the most traumatic situations were less likely to suffer health ... surveyed Army troops fighting in Iraq, could have implications for ... events such as death. Training these first-responders to think in ...
... (RA) who are current smokers were less likely to achieve ... inhibitors than those who never smoked. The study by researchers ... the past did not experience a lower response to these ... 2011 issue of Arthritis & Rheumatism , a journal ...
... Amanda Gardner HealthDay Reporter , MONDAY, Jan. 3 ... cancer on the left side of the colon, new research ... right side. The finding contradicts some previous research that ... However, the right-side benefit shown in the new study, published ...
... FOR MODERATE TO SEVERE ASTHMA ... is safe and effective an add-on treatment to corticosteroids for ... Uruguay, Argentina, and Chile performed a meta-analysis on eight trials ... At the end of the steroid reduction phase, patients taking ...
... The rapid growth in use of medical diagnostic imaging, ... radiation exposure in adults and the potential for future cancer ... led by University of Michigan researchers now shows that kids ... routine clinical care, and highlights the importance of initiatives to ...
Cached Medicine News:Health News:Estrogen May Play Role in Rising Rates of Head, Neck Cancer 2Health News:MSU leads first study of resiliency on the battlefield 2Health News:Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 3Health News:News briefs from the January issue of Chest 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 3
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... conventional methods developed to prevent and eradicate the prevalence ... These methods are confined to low specificity, safety and ... to look for a better solution. It has been ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... , LAUSANNE, Switzerland, October 15 ... low-cost, integrated molecular and,immunodiagnostics based on its proprietary micro-technology ... equity financing round. The,Company raised EUR 10 million ( ... investors. , The deal was ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the ... http://www.cordblood-america.com ) focused on bringing the life ... for families nationwide and internationally, today addressed shareholder questions ... interview of Matthew Schissler, founder and CEO, by analyst ...
Cached Medicine Technology:Biocartis Raises EUR10 Million in Series A Financing Round 2Biocartis Raises EUR10 Million in Series A Financing Round 3Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 2Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 3
For the quantitative in vitro determination of Lactate Dehydrogenase (LD) in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: